Cumberland Partners LTD Pfizer Inc Transaction History

Cumberland Partners LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$46.53 - $55.17 $41,877 - $49,653	900 Added 6.12%	15,610 $818,000
Q1 2022 May 10, 2022	BUY	$45.75 - $56.69 $217,678 - $269,731	4,758 Added 47.81%	14,710 $761,000
Q4 2021 Feb 10, 2022	BUY	$41.32 - $61.25 $411,216 - $609,560	9,952 New	9,952 $588,000
Q3 2018 Nov 15, 2018	SELL	$34.47 - $41.81 $206,820 - $250,860	-6,000 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $197,879 - $210,959	6,000 New	6,000 $218,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Cumberland Partners LTD, based on Form 13F filings with the SEC.

Stay updated on Cumberland Partners LTD with notifications on news.